Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Menopausal since ≥ 1 year~* ≥ 5 hot flushes /24 hours~* Hyperhidrosis Scale score ≥ 2~Exclusion Criteria:~* Affections like asthma, COPD, depression, diabetes, epilepsy, hyper- and hypothyreosis, malign tumours

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Sage tablets (Type: EXPERIMENTAL): Sage extract, 3400 mg , DER 1:17, in once daily application over 12 weeks treatment phase
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, matching the verum in size and appearance, in once daily application over 12 weeks treatment phase

Based on this trial design, predict the completion outcome and termination type (if applicable).